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ess: a.wewel@pulmoreSummary The 6-min walking (6MWD) and 6-min treadmill distance (6MTD) are
often used as measures of exercise performance in patients with COPD. The aim of
our study was to assess their relationship to daily activity in the course of an exercise
training program.
Eighty-eight patients with stable COPD (71m/17 f; mean7SD age, 6078 year;
FEV1, 43714% pred) were recruited, 66 of whom performed a hospital-based 10-day
walking training, whereas 22 were treated as control. On day 1 6MTD, and on days 8
and 10, 6MTD and 6MWD were determined. In addition, patients used an
accelerometer (TriTrac-R3Ds) to record 24 h-activity, whereby training sessions
were excluded.
In both groups there was a linear relationship (rX0:84 and Po0:0001) between
6MTD and 24 h-activity, the slope of which was 2.5-fold greater in the training group
(Po0:01). Similar relationships emerged for 6MWD. There was no association
between baseline 6MTD, FEV1 or BMI and any of the other measures.
These data suggest that daily activity did not markedly vary with exercise
capacity under baseline conditions. Participation in a training program increased
activity significantly stronger than predicted from the gain in exercise capacity. This
underlines the importance of non-physiological, patient-centered factors associated
with training in COPD.
& 2004 Elsevier Ltd. All rights reserved.Elsevier Ltd. All rights reserved.
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Table 1 Patients’ characteristics.
Training
group
Control
group
Sex (m/f) 51/15 20/2
Age (year) 61.278.6 58.476.7
BMI (kg/m2) 24.573.0 23.874.9
FEV1 (L) 1.3070.49 1.4570.51
FEV1 (% predicted) 41.9713.9 46.9715.1
Long-term oxygen
therapy (n)
23 8
Inhaled/oral
corticosteroids (n)
24 6
b2-agonists/
anticholinergics (n)
61 20
Mean values7SD are given.
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The 6-min walking distance (6MWD) and the
6-min treadmill distance (6MTD) have been intro-
duced as measures of exercise capacity in patients
with COPD1,2 and studies have demonstrated a
relationship between these measures and daily
activity as quantified by an accelerometer.3,4 It is
known that training programs, as part of pulmonary
rehabilitation, are capable of improving exercise
capacity.5–9
This raises the question whether the relation-
ship between exercise capacity and daily activity
depends on the patient’s participation in a
training program. Such an effect seems well
possible, as one of the benefits of training pro-
grams is the gain in self-reliance and capability to
extend one’s activity to the individual limits.10 An
effect on activity would be apparent, if daily
activity would be altered outside the training
periods, and a gain in activity exceeding that
predicted by exercise capacity would reflect a
benefit of training, that is not attributable to
muscle performance and likely to reflect altered
behavior. Provided that such an effect exists,
predictions from exercise capacity on activity
would have to take into account the presence of
training.
Based on these considerations, we assessed the
relationship between 6MWD, 6MTD and daily
activity as measured by an accelerometer in
patients with mild to severe, stable COPD, who
either participated in a 10-day hospital-based
training program or were assigned to a control
group.Patients and methods
Patients
Eighty-eight patients with COPD and FEV1 p75%
predicted11 (71m/17 f; mean7SD age, 6078 year;
FEV1, 43714% predicted; BMI 24.373.6 kg/m
2)
were studied, 66 of whom performed a 10-day
walking training and 22 of whom were treated as
control. There were no statistically significant
differences between groups regarding patients’
characteristics, including anti-obstructive and
anti-inflammatory treatment (Table 1). The diag-
nosis of COPD was established according to inter-
national guidelines12 and none of the patients
showed a significant airway disease other than
COPD. Medication was kept constant during the
course of the study.Study design
Patients were recruited from a cohort that was
considered for participation in a supervised training
program. Before entry into the study, they were
assigned to the training or the control group,
whereby every fourth of the consecutive patients
was allocated to the control group. All patients
then performed three treadmill tests in order to
become familiar with the procedure.2 Subse-
quently, patients of the training group underwent
a 10-day supervised training program, comprising a
6MTD and 5 walking sessions per day. In each
walking they achieved X75% of the 6MTD of the
respective day within 15min, similarly to pre-
viously used protocols.7,8 The training was orga-
nised as supervised walks on the aisle separated by
at least 1 h and spread over the whole day. Patients
were not encouraged to perform training outside
the defined sessions. The control group did not
participate in training but was otherwise treated in
the same way as the training group concerning
medication and physiotherapy. In addition, all
patients participated in an educational program
of 1 h/week regarding their disease.
In both groups 6MTD was assessed on day 1.
Furthermore, both 6MTD and 6MWD were assessed
on days 8 and 10, and patients additionally wore a
triaxial accelerometer (TriTrac-R3Ds, Stayhealthy,
Inc., Monrovia, CA, USA) on these days to record
24-h activity (DA24).4,13 The accelerometer was set
to an integration period of 1min in order to achieve
a sufficient time resolution for the identification of
counts. In the evaluation of accelerometer counts
we took care to exclude all training sessions,
measurements of 6MTD and 6MWD, as well as
related activities such as walks to and from the
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followed established procedures.2,9Data analysis
Mean values and standard deviations (SD) or
standard deviations of mean (SEM) were computed
for all variables. In the final evaluation the average
of data assessed on days 8 and 10 was taken (day 8/
10, see the next section) and was compared to data
from day 1. For statistical comparisons the paired
and unpaired t-test were employed. Linear regres-
sion analysis was used to quantify the relationship
between 6MWD or 6MTD and daily activity. The
relationship between activity and baseline FEV1 or
BMI or the gain in 6MTD over 10 days was assessed
in the same way. Confidence intervals of slopes
were used to compare regression coefficients
between groups. Statistical significance was as-
sumed for Po0:05:Results
In the training group, the gain in 6MTD and 6MWD
on day 10 was 14.1% and 11.4%, respectively,
compared to day 8, while the gain in DA24 was
18.1%. Corresponding values in the control group
were 3.5%, 4.5%, and 7.5%. As the ratio between
these changes was similar in both groups, we took
the individual average of each of these variables
over days 8 and 10 for final analysis.
When comparing 6MTD between days 1 and 8/10,
the training group showed a significant increase
(Po0:0001; Table 2). The same was true for the
control group (P ¼ 0:040), but the change wasTable 2 Results of training.
Training
group
Control
group
6MTD, day 1 (m) 287.2784.3 303.6773.1
6MTD, day 8/10
(m)
496.67100.5 361.17107.4*
Delta 6MTD, days
8/101 (m)
209.57132.3 57.57123.5*
6MWD, day 8/10
(m)
579.77100.5 487.7792.5*
Activity, day 8/10
(counts per day)/
1000)
126.2737.0 72.2713.6*
Mean values7SD are given.
*Po0.0005 between groups.smaller than that in the training group (Po0:0001).
A similar difference between groups emerged for
6MWD (P ¼ 0:0003) and DA24 (Po0:0001) assessed
on day 8/10. In both training (D ¼ 83:1 9:8m;
Po0:0001) and control group (D ¼ 126:6 12:6m;
Po0:0001), 6MWD on day 8/10 was larger than
6MTD on day 8/10. In patients who showed changes
in 6MTD between days 1 and 8/10 of not more than
750m, activity was significantly higher in the
training compared to the control group (n ¼ 9 and
n ¼ 7; P ¼ 0:0027).
There was a linear relationship between 6MTD
and DA24 (Fig. 1A). The mean7SEM slope of the
regression line was 308.6725.0 counts/m
(r ¼ 0:84; Po0:0001) in the training group and
119.479.3 counts/m (r ¼ 0:94; Po0:0001) in the
control group. These slope were significantly
different (Po0:01). A similar relationship emerged
for DA24 vs. 6MWD (Fig. 1B), where the slope was
227.4736.1 counts/m (r ¼ 0:62; Po0:0001) in the
training group and 106.2722.7 counts/m
(r ¼ 0:72; P ¼ 0:00014) in the control group. Again,
slopes were different (Po0:01). A significant
association was also obtained in both groups, when
plotting DA24 against the increase in 6MTD
between days 1 and 8/10 (Fig. 1C). The slopes
were 176.2727.1 counts/m (r ¼ 0:63; Po0:0001) in
the training and 86.5715.1 counts/m
(r ¼ 0:79; Po0:0001) in the control group and again
significantly different (Po0:01). In contrast, DA24
on day 8/10 was not associated with baseline 6MTD
assessed on day 1 (Fig. 1D).
We additionally performed regression analyses of
the accelerometer count accumulated during a 6-
min test against the distance achieved in that test.
In each case, the relationship was statistically
highly significant, the average slopes being 18.20
counts/m in the treadmill test and 19.65 counts/m
in the walking test, with similar values in both
groups.
There was no significant relationship between
baseline FEV1 and 6MTD on day 1, or DA24 or 6MTD
on day 8/10. The same was true for the difference
between 6MTD on days 1 and 8/10, or 6MWD on
day 8/10. Correlation coefficients were always
o0.20 in both the training and control group. The
same was found for BMI.Discussion
Our data indicated that in patients with COPD daily
activity was related to exercise capacity under
baseline conditions but the increase in activity with
increasing exercise capacity was small. Compared
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Figure 1 Relationship between daily activity at the end of the training period (day 8/10) and 6MTD (panel A) or 6MWD
(panel B) on day 8/10, or 6MTD on day 1 (panel C), or the difference in 6MTD between days 8/10 and 1 (panel D). For
variables referring to day 8/10 individual mean values of the data obtained on days 8 and 10 are shown. Open circles
indicate patients of the control group, closed circles those of the training group. The horizontal open bars in panels A
and C visualize the change of 6MTD in the control group, and the closed bars that in the training group.
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activity to a greater extent than predicted from the
concomitant gain in exercise capacity.
The effectiveness of exercise training in COPD
has been demonstrated in many studies, and
current guidelines strongly recommend it as an
integral part of pulmonary rehabilitation.14,15
There are different opinions about the most
efficient mode of training16 and the optimal choice
seems to depend on the severity of the disease. In
addition, different outcome measures can show
different results, as known for walking vs. treadmill
distance.17 Our data also demonstrated higher
values for 6MWD than for 6MTD. Irrespective of
this, various approaches have been shown to be
effective. Our data, though limited to short-term
intervention, support this view and additionally
suggest that a moderate walking program, that
appears to be best suited for severely ill patients,
also produces a significant benefit in patients with
mild to moderate disease. This was reflected in the
finding that patients with baseline FEV1 of 50–75%
predicted showed associations between walking ortreadmill distance and acticity, which were vir-
tually indistinguishable from those found in the
more severely ill patients (data not shown). Thus,
our findings seem to be equally valid in patients
with mild to moderate and severe COPD.
Daily activity, measured either by acceler-
ometer3,4 or pedometer,18,19 is known to be
associated with exercise performance in COPD,
and its reproducibility seems to be fairly high. The
instrument employed in our study has been tested
previously,3,4 whereby it was also shown that its
readings correlate with 6MWD. Activity monitors
can even be used to observe the patients’
adherence to a training program.20
One of the major effects of exercise training in
patients with COPD is the reduction in ventilation
rate for a given work load,7,8,21 resulting in lower
dyspnoea. Conversely, many patients on training
accept higher maximal dyspnoea, and this addi-
tionally favors an increase in maximal perfor-
mance.7,8 As patients with COPD show a higher
relative exercise intensity for daily activities than
healthy individuals,22 an improvement in exercise
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performance, has the potential to translate into
higher daily activity.
Owing to the limitations in daily performance,
depression is a widespread condition in severe
COPD.23,24 Therefore, any reduction in distress and
anxiety through pulmonary rehabilitation, espe-
cially after an acute exacerbation,25 and exercise
training26 might be expected to act through
positive feedback on exercise performance and/or
activity, and conversely.
To arrive at valid conclusions regarding the
correlation between activity and walking distance,
a critical analysis of data is indispensable. The fact
that patients of the training group participated in
training, per se led to higher total accelerometer
counts per day compared to control patients. To
avoid this bias, we excluded these as well as
related activities, by subtracting the respective
accelerometer counts, which could be identified by
time, from the overall readings in both groups.
A correlation between activity and 6MTD or
6MWD was also observed in the control patients.
According to the slopes of regression lines referring
to single 6-min tests, a 300m increase in 6MTD
(6MWD) was associated with an average increase of
5460 (5894) counts. Conversely, as a result of
regression analyses in control patients, the differ-
ence in daily activity between patients achieving
300 vs. 600m in the treadmill (walking) test was
35817 (31857) counts. Therefore, the tests did not
represent the major part of daily activity. The
corresponding difference in training patients was
92580 (68208) counts. These values have to be
compared with a 300 vs. 600m difference of 11354
counts for one walking plus one treadmill test in
the control group, and of 33457 counts from these
tests plus five 75% walking periods in the training
group. It is obvious that the differences in total
daily counts were about three times the differences
in counts arising from exercise tests and training.
Thus, even potential errors in the correction of
total counts are not likely to have significantly
distorted the results. These considerations render
it unlikely that the training or related activities
have artificially produced the correlations and
differences observed. They also illustrate that,
with increasing level of performance, training
patients increased their activity to a greater extent
than control patients.
At low levels of exercise capacity, activity was
very similar in both groups. The divergence
between groups emerged at higher values. Accord-
ing to the slope in the control group, the increase in
activity from days 1 to 8/10 as predicted by the
increase in 6MTD of the training group (209.5m)was 25012 counts. In fact, however, the training
group showed an increase of 64652 counts, which
was 2.6-fold as high (Figs. 1A–C). This implies that
mere participation in a training program had an
impact on activity more than 1.5-fold greater than
the effect predicted from the same rise in exercise
capacity but in the absence of training. It does not
seem far-fetched to attribute this gain in activity to
psychological factors, among which increased self-
confidence probably has played a major role. We
would like to point out, however, that we did not
measure patient-centered factors in this study and
that therefore the conclusions to be drawn from
our data in this respect are limited. There is
certainly not a close association between the
patients’ psychological profile, including anxiety
and depression, and exercise performance in
general.27 Our study included an intervention
within patients instead of correlating baseline
characteristics across patients. We believe that
this situation is much more likely to introduce a
positive relationship of activity or exercise level
with patient-centered factors.
A second implication from our observations is
that predictions from 6MTD and 6MWD on daily
activity do not seem reliable in mixed populations
of patients. By assigning patients to a training and a
control group we prepared two extreme conditions,
and it might have been that a less intense training
would have led to values in-between groups. This
suggests that predictions of daily activity can be
imprecise, especially at higher levels of exercise
capacity.
Our data also do not seem to favour the
assumption that a gain in exercise capacity per
se, for example through improvements in lung
function or physical performance in the absence of
training, causes a great increase in activity. This
was also suggested through the lack of appreciable
associations between lung function and activity or
exercise capacity. One might hypothesise that
limitations of activity by airway obstruction be-
come more obvious when activity is stressed to the
limits, e.g. through participation in a training
program. This was, however, not the case. Con-
versely, the gain in activity achieved by participa-
tion in training was apparent even in patients who
did not show a marked improvement in exercise
performance. Type and magnitude of specific daily
activities affected or elicited by the training
program were not investigated in our study. Our
data are in contrast to a recent study in which
activity was assessed during a 3-week rehabilitation
program, with very moderate increases in activity
after subtracting training periods.28 We do not have
an explanation for the discrepancy between our
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larger in our study (n ¼ 66=88 vs. 15) and possibly
the level of imposed training and emotional feed-
back was greater. These findings suggest it being
worthwhile to study factors that are capable of
modulating daily activity, as well as activity
profiles, in more detail. The same might be true
for studying training periods longer than 10 days as
well as the maintenance of the increase in activity,
when patients are back at home. At least when
measured as exercise performance, effects can be
stabilized if the training is continued as a home-
based training.8,29
The present results additionally suggest that
patients were not exhausted by the training,
thereby reducing their activity outside the pro-
gram. The short training period used by us was
unlikely to induce marked changes in peripheral
muscle physiology, and the lack of association with
BMI also suggests that physical factors such as
cachexia or overweight did not act as significant
determinants of daily activity. This is consistent
with the apparent absence of exhaustion, and again
indicates the importance of other, probably moti-
vational, factors.
In addition to physiological limitations, the
importance of psychosocial factors in patients with
COPD has long been recognized,30,31 and global
personality traits have been invoked to explain
efficacy with regard to physical performance.
Conversely, personal capabilities and perceptions
could mediate the adoption of exercise train-
ing.32,33 It seems that the use of walking instead
of ergometer training is especially suited, as the
deficiency felt by patients concerns simple day-to-
day activities.34 This is also suggested by the
effectiveness of a training program which was of
moderate intensity, but conceived as an integral
part of daily life.8,29 Therefore, daily activity may
be one of the outcomes, that have been advocated
to estimate the overall impact of the disease and
the effectiveness of interventions.35 The assump-
tion that the increase in daily activity was based on
improved self-confidence and reduced anxiety is in
accordance with observations in patients with
COPD36,37 or cardiac disease,38 with the result that
rehabilitation and the return to work were facili-
tated.39 Data from patients with severe COPD
suggest similar effects as reflected in a decreased
consumption of health resources during prolonged
training, which was not explainable through the
improvement in function.29
In summary, our data suggest that in patients
with COPD in the absence of a training program
daily activity does not markedly depend on exercise
capacity. Participation in such a program, however,raised activity markedly, and the magnitude of
increase was greater than that predicted from the
gain in exercise capacity alone. These findings
suggest the importance of motivational factors
associated with training in patients with COPD.Acknowledgements
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